Filing Details

Accession Number:
0001179110-21-008305
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-19 16:16:06
Reporting Period:
2021-08-17
Accepted Time:
2021-08-19 16:16:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1017832 P Martin Sutter 22 Cherry Hill Drive
Danvers MA 01923
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Disposition 2021-08-17 443 $323.19 168,947 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-17 202 $324.36 168,745 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-17 100 $324.94 168,645 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-17 800 $326.61 167,845 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-17 1,550 $327.45 166,295 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-17 470 $328.48 165,825 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-17 185 $328.87 165,640 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-18 669 $331.06 164,971 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-18 600 $332.34 164,371 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-18 1,781 $333.19 162,590 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-18 600 $334.19 161,990 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-18 100 $335.64 161,890 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2021-08-19 1,000 $0.00 160,890 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 G Direct
Footnotes
  1. Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  2. This price represents the sale price of the transactions on the reported date at $323.1944. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  3. This price represents the sale price of the transactions on the reported date at $324.3573. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  4. This price represents the sale price of the transactions on the reported date at $324.94. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  5. This price represents the sale price of the transactions on the reported date at $326.6050. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  6. This price represents the sale price of the transactions on the reported date at $327.4529. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  7. This price represents the sale price of the transactions on the reported date at $328.4765. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  8. This price represents the sale price of the transactions on the reported date at $328.87. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  9. This price represents the sale price of the transactions on the reported date at $331.0568. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  10. This price represents the sale price of the transactions on the reported date at $332.3433. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  11. This price represents the sale price of the transactions on the reported date at $331.1896. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  12. This price represents the sale price of the transactions on the reported date at $334.1850. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  13. This price represents the sale price of the transactions on the reported date at $335.64. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  14. This transaction represents a donation to a charity.